EP3046627
MODULATION OF EFFEROCYTOSIS PATHWAYS FOR TREATMENT OF ATHEROSCLEROTIC DISEASE
:
EP einkaleyfi: Þýðing ekki lögð inn:
15.9.2014:
23.10.2019:
14845184.2
:
14.9.2034
:
MODULATION OF EFFEROCYTOSIS PATHWAYS FOR TREATMENT OF ATHEROSCLEROTIC DISEASE
15.9.2014
23.10.2019
:
The Board of Trustees of the Leland Stanford Junior University:
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, 94305-2038, Stanford, CA, US
:
LEEPER, Nicholas J.:
Stanford, California, US
:
WEISSMAN, Irving L.:
Stanford, California, US
:
201361879562 P:
18.9.2013:
US
:
US2014055680:
15.9.2014
:
A61K 31/519, A61K 31/7068, A61P 9/10